Collaborations

Creative Biolabs, Your Immuno-Oncology Partner

Looking for partners to facilitate your research in immuno-oncology? With over 12 years of expertise in therapeutic antibody discovery and development, Creative Biolabs has established itself as a leader in contract research organization (CRO), providing comprehensive services from target selection to IND regulatory approval. With advanced platforms for antibody engineering, production, and testing, along with strong regulatory knowledge, we ensure efficient project execution. Our innovative Next-IO™ programs focus on immune-targeting therapies, and we guarantee full intellectual property rights for clients.

Get Your Customized Service →

The Structure of Antibody. (Creative Biolabs Authorized)

Why Choose Us?

Extensive Expertise & Innovation

With over 12 years of innovation, Creative Biolabs has established itself as a leading contract research organization (CRO) specializing in the discovery and development of therapeutic antibodies, including monoclonal and bispecific antibodies. Our experience spans various indications, focusing on cancer treatments and unmet medical needs. Backed by senior scientists with more than 10 years of experience, we provide state-of-the-art end-to-end solutions, guiding clients from target selection to IND regulatory approval.

Our Expertise and Innovation. (Creative Biolabs Authorized)

Comprehensive Antibody Discovery Process

Creative Biolabs offers a streamlined process that covers every step of the antibody drug development process, from discovery to production. We are also proficient in providing single-tailored biological testing to meet your specific needs. Our regulatory expertise ensures that clients receive fully compliant data within the promised timelines, helping to accelerate the drug discovery process. Our services include but not limited to:

TherapeuticalAntibody Discovery
Biologics Testing (Binding Assays, Tumor Marker Assay)
Development for Therapeutic Antibody & Protein
Preclinical Testing (In Vitro ADME, In Vivo DMPK)
cGMP Manufacturing
IND Regulatory Services
Modality (ADC, BsAb, Next CAR-T Therapy)

Innovative Programs

The Next-IO™ programs focus on developing novel therapeutic antibodies targeting the immune system, including T cells, B cells, NK cells, dendritic cells, and macrophages. These innovative programs aim to develop effective treatments for cancer through advanced strategies and collaboration.

	Programs	Related Cells/Antigens	Examples
ImmuneSystem Cells	Next-IO™ APC-Related Therapeutics	APC	Anti-CD40 Anti-CD70 Anti-OX40L
	Next-IO™ T Cell-Related Therapeutics	T Cell	Anti-FGL1 Anti-Siglec-15 Anti-TIM3 Anti-4-1BB
	Next-IO™ NK Cell-Related Therapeutics	NK Cell	Fusion Protein of NKG2D Anti-sMIC Anti-CD48
	Next-IO™ B Cell-related Therapeutics	B Cell	In development
	Next-IO™ Macrophages-Related Therapeutics	Macrophage	TAM-Related
Tumor	Next-IO™ Tumor-Associated Antigens	Tumor-Associated Antigens	Anti-CD73 Anti-GPVI Anti-Phosphatidylserine
Tumor	COVID-19 Recovered Patient-Derived Anti-SARS-CoV-2 Therapeutic Antibody Development	COVID-19 Patient-Derived cells	Anti-SARS-CoV-2

Complete Intellectual Property. (Creative Biolabs Authorized)

Intellectual Property Ownership

We ensure that clients have full intellectual property rights and ownership of all therapeutic antibodies and proteins developed. Creative Biolabs guarantees complete support in managing risks, allowing clients to lead the process with peace of mind.

Collaboration & Flexibility

Creative Biolabs actively seeks collaborative partnerships for co-developing programs from the discovery phase to IND enabling. We offer flexible collaboration models, including shared development costs or licensing opportunities for commercial partners. Our strong quality control protocols and understanding of global regulatory requirements help bring projects to market efficiently.

Partnership. (Creative Biolabs Authorized)

Partner with Creative Biolabs

With over several years of expertise in therapeutic antibody discovery and development, Creative Biolabs has partnered with many leading enterprises to facilitate their discovery of innovative medicines. We provide comprehensive services including antibody discovery, engineering, production, and testing with our advanced Next-IO™ Programs. If you want to know more details of our services, please do not hesitate to contact us!

Resources

Download our brochure